Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months

NCT00601731 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Disease

Interventions

BIOLOGICAL: MenACWY-CRM197
BIOLOGICAL: Blood test

Sponsor

Novartis Vaccines

Collaborators

[object Object]